Vividion Therapeutics Earns First Milestone Payment for Advancement of Program Addressing High Value Oncology Target

SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics Earns First Milestone Payment for Advancement of Program Addressing High Value Oncology Target
Click here to view original post